Question special

Why do we call it "black box," and how does that characteristic make it even more imperative for us to come up with a scheme to ensure the safety and efficacy of these technologies and applications? Professors Price and Cortez have written extensively on this matter. Recently, Professor Price taught a Harvard Law class on this very issue, and discussed the role that patients, providers, insurers, and governmental entities may play.